Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.

H. Kantarjian(The University of Texas MD Anderson Cancer Center), Moshe Talpaz(University of Michigan–Ann Arbor), S O'Brien(The University of Texas Health Science Center at Houston), Eric J. Feldman(The University of Texas MD Anderson Cancer Center), Elihu Estey(The University of Texas MD Anderson Cancer Center), Charles Koller(The University of Texas MD Anderson Cancer Center), Sherry Pierce(The University of Texas MD Anderson Cancer Center), M Keating(The University of Texas MD Anderson Cancer Center), Miloslav Beran(The University of Texas MD Anderson Cancer Center)
Journal of Clinical Oncology
May 1, 1992
10.1200/jco.1992.10.5.772
Cited by 114

Related Papers

Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
|Blood|1997|1.2k
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2005|951
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
|Journal of Clinical Oncology|1998|927
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818